• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Danaher Could Trade Higher

I do not find enough technical reasons to recommend new long positions at this point in time.
By BRUCE KAMICH
Jan 11, 2021 | 02:50 PM EST
Stocks quotes in this article: DHR, JPM

Danaher Corp. (DHR) is a science and technology innovator and will be wrapping up the JP Morgan (JPM) health care conference on Wednesday, hopefully with an update on their vaccine progress.

Let's check out the charts.   

In this daily bar chart of DHR, below, we can see that prices are "flirting" with new highs as they retest the November peak. DHR is trading above the flat 50-day moving average line and above the rising 200-day line.
 
The On-Balance-Volume (OBV) line looks like it is leading the price action and is already at a new high. The Moving Average Convergence Divergence (MACD) oscillator has turned up above the zero line for a buy signal. 
 
 
 
In this weekly bar chart of DHR, below, we can see how prices have performed since they broke out from a base pattern around $100. DHR is trading above the rising 40-week moving average line.
 
The OBV line is generally positive and the MACD oscillator is close to a new buy signal.  
 
 
 
In this daily Point and Figure chart of DHR, below, we can see a potential upside price target in the $291 area. 
 
 
 
Bottom line strategy: The charts of DHR are mixed but the trend is still pointed up. Hold existing longs and raise stops to $219. I do not find enough technical reasons to recommend new long positions at this point in time.
 

(JP Morgan is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells JPM? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare

More from Investing

Excitement Builds for SPAC That Will Bring Topps Back as Public Entity

Jonathan Heller
Apr 19, 2021 11:30 AM EDT

The market for sports cards is going crazy, which adds to the anticipation of the sports cards maker going public once again.

Here's Where I'd Buy Village Farms

Timothy Collins
Apr 19, 2021 11:26 AM EDT

I'm a put seller of VFF here.

Fundamentals and Valuation Don't Matter Right Now

James "Rev Shark" DePorre
Apr 19, 2021 11:04 AM EDT

I don't recall a market where sentiment among traders was this negative while the major indices have been so strong.

Investing in Coca-Cola Is a Matter of Taste

Stephen Guilfoyle
Apr 19, 2021 11:00 AM EDT

You are not long and 'wrong' KO, just because I am long PepsiCo.

Will Jack Ma Have to Sell Out of Ant and Alibaba?

Alex Frew McMillan
Apr 19, 2021 10:45 AM EDT

Ant and Alibaba are in talks with Chinese regulators about how the companies can proceed, perhaps without their figurehead.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:05 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How recency bias and the Pareto Principle impact y...
  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login